[ET Net News Agency, 27 December 2024] ALPHAMAB-B (09966) rose 10.8% to HK$3.81,
breaking above the 20-D SMA of HK$3.669.
It hits an intra-day high of HK$3.94, and an intra-day low of HK$3.4. The total shares
traded was 1.9 million, with a value of HK$6.82m. The active buy/sell ratio is 69:31, with
net buying turnover of HK$2.57m. BARCLAYS CAPITAL ASIA accounts for greatest net
responsive buying turnover of HK$188,459, with volume weighted average price of HK$3.49.
CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of
HK$235,489, with volume weighted average price of HK$3.462. The stock has risen a combined
12.1% over the past 2 consecutive trading days.

Basic Information
=================

---------------------------------
Nominal 3.810 % Chg +10.76%
High 3.940 Low 3.400
Shares Tr 1.9m Turnover 6.82m
10-D SMA 3.542 %H.V 58.177
20-D SMA 3.669 VWAP 3.580
50-D SMA 3.944 RSI14 51.962
---------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 69:31, with net buying
turnover of HK$2.57m, rising a combined 12.1% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
ALPHAMAB-B (09966) 3.81 +10.76
GENSCRIPT BIO (01548) 9.89 -1.00
INNOVENT BIO (01801) 35.70 -0.28
EVEREST MED-B (01952) 47.05 +0.11
CARSGEN-B (02171) 8.29 -8.70
WUXI BIO (02269) 17.32 -0.80
WUXI APPTEC (02359) 54.25 -2.52
PHARMARON (03759) 13.48 -3.85
BEIGENE (06160) 108.30 +1.12
AKESO (09926) 59.00 -1.99
---------------------------------------------
(ed)